1. Home
  2. HALO vs TIMB Comparison

HALO vs TIMB Comparison

Compare HALO & TIMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • TIMB
  • Stock Information
  • Founded
  • HALO 1998
  • TIMB 1998
  • Country
  • HALO United States
  • TIMB Brazil
  • Employees
  • HALO N/A
  • TIMB N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • TIMB Telecommunications Equipment
  • Sector
  • HALO Health Care
  • TIMB Telecommunications
  • Exchange
  • HALO Nasdaq
  • TIMB Nasdaq
  • Market Cap
  • HALO 7.4B
  • TIMB 8.0B
  • IPO Year
  • HALO N/A
  • TIMB 1998
  • Fundamental
  • Price
  • HALO $47.91
  • TIMB $17.76
  • Analyst Decision
  • HALO Buy
  • TIMB Hold
  • Analyst Count
  • HALO 9
  • TIMB 4
  • Target Price
  • HALO $63.56
  • TIMB $17.00
  • AVG Volume (30 Days)
  • HALO 3.0M
  • TIMB 297.0K
  • Earning Date
  • HALO 05-06-2025
  • TIMB 05-06-2025
  • Dividend Yield
  • HALO N/A
  • TIMB 6.70%
  • EPS Growth
  • HALO 55.40
  • TIMB 17.22
  • EPS
  • HALO 3.76
  • TIMB 0.25
  • Revenue
  • HALO $1,084,306,000.00
  • TIMB $4,490,458,172.00
  • Revenue This Year
  • HALO $24.79
  • TIMB $8.16
  • Revenue Next Year
  • HALO $22.65
  • TIMB $4.83
  • P/E Ratio
  • HALO $13.36
  • TIMB $14.09
  • Revenue Growth
  • HALO 25.64
  • TIMB 6.00
  • 52 Week Low
  • HALO $41.28
  • TIMB $11.32
  • 52 Week High
  • HALO $70.51
  • TIMB $18.39
  • Technical
  • Relative Strength Index (RSI)
  • HALO 32.31
  • TIMB 67.90
  • Support Level
  • HALO $58.38
  • TIMB $16.72
  • Resistance Level
  • HALO $69.94
  • TIMB $17.68
  • Average True Range (ATR)
  • HALO 3.37
  • TIMB 0.34
  • MACD
  • HALO -1.11
  • TIMB 0.07
  • Stochastic Oscillator
  • HALO 1.78
  • TIMB 96.05

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About TIMB TIM S.A. (Each representing 5)

TIM, which is 67%-owned by Telecom Italia, is the third largest wireless carrier in Brazil, with 62 million subscribers, equal to about 24% of the market. The firm also owns 49% of I-Systems, an infrastructure partnership that is expanding its network footprint across Brazil. I-Systems can provide broadband service to about 9 million locations, equal to 10%-15% of the country. TIM leases capacity on the venture's network to serve retail broadband customers under the UltraFibra brand. TIM also resells fiber network access from other providers, including Oi's former infrastructure business V.tal. In total, TIM claims it can offer fixed broadband service to about 16 million locations.

Share on Social Networks: